Research & Analytics

Uncover the story the numbers tell with a robust data set on a variety of clinical and practice topics, beyond just quality.

Sample Use Cases

Data from the EMDI Registry can help pharma companies accelerate and improve clinical trials by:

• Informing the design of clinical trial protocols
• Leveraging RWD for synthetic control arms or adaptive trial designs
• Identifying appropriate inclusion/exclusion criteria for the targeted patient population
• Supporting site selection by estimating the size of the eligible patient population per geographic region

Using RWD to study the usage of off-label indications can provide many benefits to pharma companies such as:

• Uncovering insights into drug effectiveness and differentiation for various patient profiles
• Supporting regulatory approval of new indications in lieu of requiring additional clinical trials, saving time and decreasing costs
• Improving patient access to treatments that were formerly off-label

Pharma companies can leverage the RWD from the EMDI Registry to improve medication compliance by:

• Identifying drivers of medication non-adherence by analyzing demographic, social, and medical data
• Supporting development of advanced analytics to predict patients who are more likely to become non-adherent
• Developing improved patient engagement strategies

Pharma companies can leverage data from the EMDI Registry and improve market access by:

• Gaining RWD on drug usage outside of clinical trials
• Informing the design of value-based contracts
• Securing formulary status
• Tracking patient outcomes to justify pricing

Analyzing the EMDI Registry dataset can enhance pharmacovigilance activities by:

• Discovering previously unrecognized drug-drug, drug-supplement and other relevant interactions
• Identifying subgroups of patients that are at higher risk of adverse events due to comorbid medical conditions or other predisposing risk factors